2020
DOI: 10.1016/j.dsx.2020.06.060
|View full text |Cite
|
Sign up to set email alerts
|

BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

19
82
2
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 92 publications
(104 citation statements)
references
References 3 publications
19
82
2
1
Order By: Relevance
“…On the other hand, Zachary et al reported better results concerning changes in the body weight, were the 22% reported an increase in this parameter, although this survey only analysed the period of initial confinement [13]. In this sense, it is important to consider that obese subjects with COVID-19 have a worse prognosis since they have a higher risk of intensity care unit (ICU) admission and invasive mechanical ventilation [24,25].…”
Section: Discussionmentioning
confidence: 94%
“…On the other hand, Zachary et al reported better results concerning changes in the body weight, were the 22% reported an increase in this parameter, although this survey only analysed the period of initial confinement [13]. In this sense, it is important to consider that obese subjects with COVID-19 have a worse prognosis since they have a higher risk of intensity care unit (ICU) admission and invasive mechanical ventilation [24,25].…”
Section: Discussionmentioning
confidence: 94%
“…Emerging research has suggested that higher BMI is associated with increased LOS but decreased mortality for patients with ARDS [12,13]. However, recent fi ndings indicate that COVID-19 related deaths are more prevalent in patients with higher BMI [14] and that obesity should be considered an independent risk factor for mortality in patients with COVID-19 [15]. Obesity has been also linked to increased incidence of hospital admission in younger patients [16].…”
Section: Introductionmentioning
confidence: 99%
“…Given the expected initial limits on vaccine supply, it is very likely that choices will need to be made based on a number of different criteria: Individual health benefits : Ideally, this would take into account trial results on efficacy and adverse effects, and model the implications of using the vaccine for different individuals or groups within the general population. Given the emerging evidence on the relative risk of mortality based on databases such as the UK Biobank [ 23 ], it should be possible to estimate potential quality-adjusted life-years gained [ 24 ]. Societal health benefits : Susceptible, infected and recovered (SIR) models [ 25 ] that take into account the level and nature of population mixing could help to quantify the likely positive externalities associated with a vaccination programme.…”
mentioning
confidence: 99%
“…Individual health benefits : Ideally, this would take into account trial results on efficacy and adverse effects, and model the implications of using the vaccine for different individuals or groups within the general population. Given the emerging evidence on the relative risk of mortality based on databases such as the UK Biobank [ 23 ], it should be possible to estimate potential quality-adjusted life-years gained [ 24 ].…”
mentioning
confidence: 99%